Systematic review: The role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - Current evidence and potential clinical applications

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 5, 2014, Pages 409-421

  Touchefeu, Y ^a   Montassier, E ^b   Nieman, K ^c   Gastinne, T ^a   Potel, G ^b   Bruley Des Varannes, S ^a   Le Vacon, F ^d   De La Cochetiere M F ^e  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Biofortis Clinical Research   (United States)

^d Biofortis   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTINEOPLASTIC AGENTS; DIARRHEA; HUMANS; INTESTINAL DISEASES; INTESTINES; MICROBIOTA; MUCOSITIS; NEOPLASMS; PROBIOTICS; RADIATION INJURIES;

EID: 84905858666     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12878     Document Type: Review

References (70)

1. Peterson DE, Bensadoun RJ, Roila F,. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 2011; 22 (Suppl 6): vi78-84.
2. Benson AB 3rd, Ajani JA, Catalano RB, et al,. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004; 22: 2918-26.
3. Keefe DM, Schubert MM, Elting LS, et al,. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109: 820-31.
4. Falcone A, Ricci S, Brunetti I, et al,. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 2007; 25: 1670-6.
5. Bosset JF, Calais G, Daban A, et al,. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004; 40: 219-24.
6. Sasse AD, Clark LG, Sasse EC, Clark OA,. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int J Radiat Oncol Biol Phys 2006; 64: 784-91.
7. Gu J, Zhu S, Li X, Wu H, Li Y, Hua F,. Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials. PLoS ONE 2014; 9: e95968.
8. Garcia-Lafuente A, Antolin M, Guarner F, et al,. Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 1997; 272: G10-5.
9. Hakansson A, Tormo-Badia N, Baridi A, et al,. Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin Exp Med 2014. doi: 10.1007/s10238-013-0270-5
10. Verma N, Verma R, Kumari R, Ranjha R, Paul J,. Effect of salicin on gut inflammation and on selected groups of gut microbiota in dextran sodium sulfate induced mouse model of colitis. Inflamm Res 2014; 63: 161-9.
11. Berry D, Schwab C, Milinovich G, et al,. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J 2012; 6: 2091-106.
12. Johansson ME, Gustafsson JK, Sjoberg KE, et al,. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS ONE 2010; 5: e12238.
13. Sommer F, Adam N, Johansson ME, Xia L, Hansson GC, Backhed F,. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. PLoS ONE 2014; 9: e85254.
14. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-14.
15. Rooks MG, Veiga P, Wardwell-Scott LH, et al,. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J 2014; 8: 1403-17. doi: 10.1038/ismej.2014.3
16. Tong M, McHardy I, Ruegger P, et al,. Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism. ISME J 2014. doi: 10.1038/ismej.2014.64
17. Morgan XC, Tickle TL, Sokol H, et al,. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13: R79.
18. Sonis ST,. The pathobiology of mucositis. Nat Rev Cancer 2004; 4: 277-84.
19. Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM,. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol 2009; 63: 239-51.
20. Larsen A, Bjorge B, Klementsen B, et al,. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncol 2007; 46: 639-50.
21. Anthony L, Bowen J, Garden A, Hewson I, Sonis S,. New thoughts on the pathobiology of regimen-related mucosal injury. Support Care Cancer 2006; 14: 516-8.
22. Stringer AM,. Interaction between host cells and microbes in chemotherapy-induced mucositis. Nutrients 2013; 5: 1488-99.
23. Cario E,. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction. Curr Opin Gastroenterol 2008; 24: 725-32.
24. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R,. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-41.
25. Cario E,. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 2005; 54: 1182-93.
26. Carneiro-Filho BA, Lima IP, Araujo DH, et al,. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci 2004; 49: 65-72.
27. Russo F, Linsalata M, Clemente C, et al,. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC cancer 2013; 13: 56.
28. Nejdfors P, Ekelund M, Westrom BR, Willen R, Jeppsson B,. Intestinal permeability in humans is increased after radiation therapy. Dis Colon Rectum 2000; 43: 1582-7.
29. Melichar B, Zezulova M,. The significance of altered gastrointestinal permeability in cancer patients. Curr Opin Support Care 2011; 5: 47-54.
30. Keefe DM, Brealey J, Goland GJ, Cummins AG,. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47: 632-7.
31. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC,. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 2011; 141: 769-76.
32. van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ,. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 2010; 6: e1000879.
33. Caballero-Franco C, Keller K, De Simone C, Chadee K,. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007; 292: G315-22.
34. McLaughlin MM, Dacquisto MP, Jacobus DP, Horowitz RE,. Effects of the germ free state on responses of mice to whole-ody irradiation. Radiat Res 1964; 23: 333-49.
35. Crawford PA, Gordon JI,. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci USA 2005; 102: 13254-9.
36. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI,. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-5.
37. Imaoka A, Setoyama H, Takagi A, Matsumoto S, Umesaki Y,. Improvement of human faecal flora-associated mouse model for evaluation of the functional foods. J Appl Microbiol 2004; 96: 656-63.
38. Stringer AM, Gibson RJ, Logan RM, et al,. Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis. Exp Biol Med 2009; 234: 430-41.
39. Von Bultzingslowen I, Adlerberth I, Wold AE, Dahlen G, Jontell M,. Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol Immunol 2003; 18: 278-84.
40. Stringer AM, Gibson RJ, Logan RM, et al,. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp Biol Med 2007; 232: 96-106.
41. Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Keefe DM,. Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol Ther 2008; 7: 1919-25.
42. Lin XB, Dieleman LA, Ketabi A, et al,. Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PLoS ONE 2012; 7: e39764.
43. Montassier E, Batard E, Gastinne T, Potel G, de La Cochetiere MF,. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 2013; 32: 841-50.
44. Johnson LB, Riaz AA, Adawi D, et al,. Radiation enteropathy and leucocyte-endothelial cell reactions in a refined small bowel model. BMC surgery 2004; 4: 10.
45. van Vliet MJ, Tissing WJ, Dun CA, et al,. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 2009; 49: 262-70.
46. Zwielehner J, Lassl C, Hippe B, et al,. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS ONE 2011; 6: e28654.
47. Montassier E, Batard E, Massart S, et al,. 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation. Microb Ecol 2014; 67: 690-9.
48. Stringer AM, Al-Dasooqi N, Bowen JM, et al,. Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases. Support Care Cancer 2013; 21: 1843-52.
49. Manichanh C, Varela E, Martinez C, et al,. The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol 2008; 103: 1754-61.
50. Nam YD, Kim HJ, Seo JG, Kang SW, Bae JW,. Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing. PLoS ONE 2013; 8: e82659.
51. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB,. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17: 259-75.
52. Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM,. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 2007; 6: 1449-54.
53. Tooley KL, Howarth GS, Lymn KA, Lawrence A, Butler RN,. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol Ther 2006; 5: 593-600.
54. Tooley KL, Howarth GS, Lymn KA, Lawrence A, Butler RN,. Oral ingestion of Streptococcus thermophilus does not affect mucositis severity or tumor progression in the tumor-bearing rat. Cancer Biol Ther 2011; 12: 131-8.
55. Smith CL, Geier MS, Yazbeck R, Torres DM, Butler RN, Howarth GS,. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr Cancer 2008; 60: 757-67.
56. Whelan K, Quigley EM,. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013; 29: 184-9.
57. Wada M, Nagata S, Saito M, et al,. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 2010; 18: 751-9.
58. Osterlund P, Ruotsalainen T, Korpela R, et al,. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 2007; 97: 1028-34.
59. Liong MT,. Safety of probiotics: translocation and infection. Nutr Rev 2008; 66: 192-202.
60. Ciorba MA, Riehl TE, Rao MS, et al,. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2- dependent manner. Gut 2012; 61: 829-38.
61. Andreyev J,. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol 2007; 8: 1007-17.
62. Kalogeridi MA, Kelekis N, Kouvaris J, et al,. Accelerated hypofractionated radiotherapy schedules in breast cancer: a review of the current literature. Rev Recent Clin Trials 2009; 4: 147-51.
63. Wedlake LJ, Shaw C, Whelan K, Andreyev HJ,. Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment Pharmacol Ther 2013; 37: 1046-56.
64. Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S,. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 1988; 39: 435-7.
65. Urbancsek H, Kazar T, Mezes I, Neumann K,. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 2001; 13: 391-6.
66. Giralt J, Regadera JP, Verges R, et al,. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 2008; 71: 1213-9.
67. Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V,. Randomized controlled trial of live Lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 2010; 5: 31.
68. Delia P, Sansotta G, Donato V, et al,. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007; 13: 912-5.
69. Taur Y, Xavier JB, Lipuma L, et al,. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012; 55: 905-14.
70. Ubeda C, Bucci V, Caballero S, et al,. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013; 81: 965-73.